Imidocarb

未知生产厂商

Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia and other parasites.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia and other parasites.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

AN OPTIMISED VETERINARY INJECTABLE FORMULATION
EP 4213818 B1申请人: BIMEDA AMEA LTD优先权: 2020
EP
WO
2 件公开
Compound sulfamonomethoxine sodium injection and preparation method thereof
CN 100586441 C申请人: JIANBO CHEN优先权: 2008
CN
2 件公开
Imidocarb dipropionate compound preparations for eperythrozoonosis for animals and preparation
CN 101214272 A申请人: UNIV SHANGHAI JIAOTONG优先权: 2007
CN
Levamisol hydrochloride compound preparations for eperythrozoonsis for animals and preparation thereof
CN 101214243 A申请人: UNIV SHANGHAI JIAOTONG优先权: 2007
CN
BLOOD PARASITICIDE
US 2012129801 A1申请人: ARTACHO ROGERIO GRASSETTO优先权: 2010
US
Veterinary compound hydrochloric acid injection and preparation method thereof
CN 102151263 B申请人: HENAN HEIMA ANIMAL PHARMACEUTICAL CO LTD优先权: 2011
CN
Preparation method of 2-(3-amino phenyl) imidazoline hydrochloride and imidocarb
CN 106957265 A申请人: GUANNAN EAST CHEMICAL CO LTD优先权: 2017
CN
An imidocarb dipropionate impurity A and a preparation method of the impurity A
CN 110256354 A申请人: QILU ANIMAL HEALTH PRODUCTS CO优先权: 2019
CN
Preparation method of imidocarb dipropionate and intermediate thereof
CN 111574455 A申请人: SHANDONG ACAD PHARMACEUTICAL SCIENCES优先权: 2020
CN
Method for recovering and purifying imidocarb
CN 111892541 A申请人: SHANDONG JIULONG HISINCE PHARMACEUTICAL CO LTD优先权: 2020
CN